Terns Pharmaceuticals, Inc. (TERN)

37.10 +0.52 (+1.41%) USD  |  NASDAQ  |  Jan 21, 10:29
More

Terns Pharmaceuticals Total Long Term Assets (Quarterly)

Total Long Term Assets (Quarterly) Chart

View Total Long Term Assets (Quarterly) for TERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Assets (Quarterly) Range, Past 5 Years

View Total Long Term Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Assets (Quarterly) Benchmarks

View Total Long Term Assets (Quarterly) Benchmarks
Start Trial
Altimmune, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade